These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18201185)

  • 1. Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.
    Agger EM; Cassidy JP; Brady J; Korsholm KS; Vingsbo-Lundberg C; Andersen P
    Immunology; 2008 Jun; 124(2):175-85. PubMed ID: 18201185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.
    Grover A; Troudt J; Foster C; Basaraba R; Izzo A
    Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of adjuvant formulation in the development of a tuberculosis vaccine.
    Baldwin SL; Bertholet S; Reese VA; Ching LK; Reed SG; Coler RN
    J Immunol; 2012 Mar; 188(5):2189-97. PubMed ID: 22291184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis.
    Kebriaei A; Derakhshan M; Meshkat Z; Eidgahi MR; Rezaee SA; Farsiani H; Mosavat A; Soleimanpour S; Ghazvini K
    Mol Biol Rep; 2016 Sep; 43(9):911-22. PubMed ID: 27251218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
    Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
    J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
    Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
    J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
    Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
    Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice.
    Jung YJ; LaCourse R; Ryan L; North RJ
    Infect Immun; 2002 Nov; 70(11):6436-43. PubMed ID: 12379724
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
    Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
    Riccomi A; Palma C
    PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
    D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
    Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.
    Aguilar D; Infante E; Martin C; Gormley E; Gicquel B; Hernandez Pando R
    Clin Exp Immunol; 2007 Feb; 147(2):330-8. PubMed ID: 17223975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.